The addition of JTT at 50 μg/mL (63.29%) or 100 μg/mL (66.45%) did not reduce apoptosis levels, suggesting that JTT does not inhibit TRAIL-induced apoptosis in OSC-19 cancer cells. This evidence concerns the gene TNFSF10 and cancer.